<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although several studies propose a chemopreventive effect of aspirin for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) development, the general use of aspirin cannot be recommended due to its adverse side effects </plain></SENT>
<SENT sid="1" pm="."><plain>As the protective effect of aspirin has been associated with an increased expression of COX-2, molecular imaging of COX-2, for instance, during confocal endomicroscopy could enable the identification of patients who would possibly benefit from aspirin treatment </plain></SENT>
<SENT sid="2" pm="."><plain>In this pilot trial, we used a COX-2-specific <z:chebi fb="0" ids="39442">fluorescent probe</z:chebi> for detection of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in mice using confocal microscopy </plain></SENT>
<SENT sid="3" pm="."><plain>Following the injection of the COX-2 probe into <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-bearing APCmin mice or mice exposed to the AOM + DSS model of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific upregulation of COX-2 could be validated with in vivo fluorescence imaging </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequent confocal imaging of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue showed an increased number of COX-2 expressing cells when compared to the <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa of healthy controls </plain></SENT>
<SENT sid="5" pm="."><plain>COX-2-expression was detectable with subcellular resolution in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and infiltrating stroma cells </plain></SENT>
<SENT sid="6" pm="."><plain>These findings pose a proof of concept and suggest the use of CLE for the detection of COX-2 expression during <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> surveillance endoscopy </plain></SENT>
<SENT sid="7" pm="."><plain>This could improve early detection and stratification of chemoprevention in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>